Mitochondria, Cytokines, and the Breath–Immune Connection: What New Research Reveals

Introduction

When researchers at Peking Union Medical College Hospital compared colon tissue from older and younger ulcerative colitis patients, they found 30 genes tied to mitochondria that behaved differently with age — and those differences tracked directly with immune cell infiltration and cytokine signaling. The 2025 study, published in Immunity & Ageing, adds to growing evidence that cellular energy machinery sits at the center of inflammation, breathing, and immune function.

Older Mitochondria Leak More Damage — and Cytokines Follow

Zhang, Lv, and colleagues induced colitis in two groups of mice: young animals aged 6–8 weeks and old animals aged 20–24 months. Both received the same 2% dextran sodium sulphate for seven days. The aged mice fared significantly worse, with visibly damaged mitochondrial structure and measurably lower ATP — the molecule cells use to store and spend energy — in colon tissue.

RNA sequencing of human colonic mucosa identified 30 mitochondria-related differentially expressed genes between adult- and elderly-onset UC. These genes were not randomly scattered across cellular functions; they clustered around mitochondrial respiratory function, and their expression patterns correlated with the composition of infiltrating immune cells in the tissue. In other words, the state of the mitochondria helped shape the local immune microenvironment.

The mechanism came into focus through the gene ALDH1L1, identified as a hub gene by protein-protein interaction network analysis. It was downregulated in both UC patients and colitis mice compared with healthy controls. When the researchers used TNF-alpha to stimulate HCT116 human colon cells after knocking down ALDH1L1, mitochondrial ROS increased, and the NLRP3 inflammasome and IL-1β — two of the most inflammatory signaling outputs in the body — rose in response.

T Cells Choose Their Cytokines Through Metabolism

A parallel line of research shows the same logic applies to adaptive immunity. A November 2024 study in Discovery Immunology, led by Matteo Certo and Claudio Mauro at the University of Birmingham and Queen Mary University of London, examined CARKL (sedoheptulose kinase), a metabolic enzyme active in the pentose phosphate pathway. Their finding: CARKL controls what cytokines T cells produce and where they migrate, by steering metabolic reprogramming.

This matters because T cells must radically change their metabolism when activated — switching from fuel-efficient oxidative phosphorylation to fast, glycolysis-driven growth. How a cell manages its mitochondria and redox balance determines whether it pumps out inflammatory cytokines like interferon-gamma and IL-17, or calmer regulatory signals. Metabolism is not background noise; it is instruction.

That principle extends to lung disease. Airway inflammation in asthma and COPD is likewise governed by cytokines and chemokines, a process we cover in detail in Asthma Inflammation: How Cytokines and Chemokines Affect Airways. The same NLRP3/IL-1β axis implicated in the colitis study also appears in cigarette smoke- and vaping-related airway damage, as described in our article on e-cigarette vapor and airway inflammation.

Why Oxygen-Exposed Tissue Feels This First

Lungs face a unique burden. They sit directly at the oxygen interface, and their epithelial cells are packed with mitochondria that must handle high oxygen throughput. High oxygen flux means high ROS potential — the same reactive molecules that spiked when ALDH1L1 was silenced. Mitochondria that are structurally intact can contain ROS; damaged ones leak it, and leaked ROS activates the NLRP3 inflammasome, driving IL-1β and downstream cytokine cascades.

Age compounds this. Both the Peking and Birmingham studies support a model in which aging mitochondria — swollen, fragmented, ATP-depleted — bias immune cells toward inflammatory outputs. This helps explain why elderly-onset inflammatory diseases are frequently more severe than the same diseases in younger patients, and why chronic low-grade inflammation (“inflammageing”) is a hallmark of aging.

Honest caveat: both studies were conducted in mice and cell lines, with human tissue used for sequencing comparison. Neither proves that modulating mitochondrial genes or CARKL in living patients would reverse disease. But they sharpen the mechanistic picture considerably.

What This Means for Respiratory Health Practice

No breathing exercise can repair a mitochondrion directly. But the stress-immune-metabolism loop these studies describe is responsive to behavioral inputs, and some evidence-backed options exist:

• Slow, paced breathing and meditation. Practices such as coherent breathing and mindfulness of breathing reduce sympathetic arousal and inflammatory tone; clinical work on trauma-informed breathwork shows stress reduction that plausibly blunts TNF-alpha-driven signaling. See our coverage of yoga and breathwork stress findings.
• Exercise and respiratory training. Aerobic exercise is among the best-documented ways to improve mitochondrial density and quality in muscle, including respiratory muscles — relevant for people with COPD, as our article on exercise plus respiratory training in COPD explains.
• Compounds under study. NAC (n-acetylcysteine) replenishes the antioxidant glutathione; curcumin and omega-3 fatty acids have shown NLRP3- and cytokine-modulating effects in early trials. Evidence remains preliminary — none replaces prescribed treatment.
• Avoiding mitochondrial insults. Tobacco and vaping vapor, chronic sleep debt, and persistent hyperventilation-linked stress all increase oxidative burden on oxygen-processing tissue.

Frequently Asked Questions

Does slow breathing actually change immune function?

Indirectly, yes. Controlled breathing reduces sympathetic stress signaling, and clinical studies of mind-body training show reductions in anxiety alongside lower inflammatory tone — though effects on cytokines specifically are still being mapped.

What is IL-1β and why does it matter for lungs?

IL-1β is a pro-inflammatory cytokine released when the NLRP3 inflammasome is activated, often by mitochondrial ROS. It drives tissue-damaging inflammation in lungs, joints, and gut alike.

Can older adults reverse mitochondrial decline?

Partially. Regular aerobic exercise, adequate protein, and good sleep reliably improve mitochondrial quality, even in later life — full reversal is not realistic.

Are these findings relevant to asthma or COPD?

Yes — the same mitochondrial–ROS–NLRP3–cytokine machinery operates in airway cells, and it is a target of active research in both diseases.

Conclusion

The Peking study quantified something clinicians had long observed: elderly-onset inflammation is more severe, and damaged mitochondria — leaking ROS, underproducing ATP, and feeding the NLRP3/IL-1β cytokine axis — are a key reason. The Birmingham work confirms immune cells make cytokine decisions through metabolism. For respiratory health, the lesson is clear: protect the cellular engines that breathe, because every cytokine signal begins as a metabolic event.

Sources:
https://pubmed.ncbi.nlm.nih.gov/39794776/
https://pubmed.ncbi.nlm.nih.gov/39669692/
https://pubmed.ncbi.nlm.nih.gov/39625496/
https://pubmed.ncbi.nlm.nih.gov/39345912/
https://pubmed.ncbi.nlm.nih.gov/39269443/